NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)

41 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q2 2025.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9,395,986 shares of 264,351,875 outstanding shares and own 3.55% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (5,980,568 shares), Candriam S.C.A. (1,132,563 shares), SG Americas Securities, LLC (876,353 shares), TWO SIGMA ADVISERS, LP (209,383 shares), UBS Group AG (184,845 shares), Aberdeen Group plc (136,471 shares), BNP PARIBAS FINANCIAL MARKETS (122,405 shares), TWO SIGMA INVESTMENTS, LP (113,262 shares), Ariose Capital Management Ltd (96,455 shares), and Alberta Investment Management Corp (74,723 shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.